Summary
This study compares the influence of two different nuclear sampling methods on the prognostic value of assessments of mean and standard deviation of nuclear area (MNA, SDNA) in 191 consecutive invasive breast cancer patients with long term follow up. The first sampling method used was ‘at convenience’ sampling (ACS); the second, systematic random sampling (SRS). Both sampling methods were tested with a sample size of 50 nuclei (ACS-50 and SRS-50). To determine whether, besides the sampling methods, sample size had impact on prognostic value as well, the SRS method was also tested using a sample size of 100 nuclei (SRS-100).
SDNA values were systematically lower for ACS, obviously due to (unconsciously) not including small and large nuclei. Testing prognostic value of a series of cut off points, MNA and SDNA values assessed by the SRS method were prognostically significantly stronger than the values obtained by the ACS method. This was confirmed in Cox regression analysis. For the MNA, the Mantel-Cox p-values from SRS-50 and SRS-100 measurements were not significantly different. However, for the SDNA, SRS-100 yielded significantly lower p-values than SRS-50.
In conclusion, compared with the ‘at convenience’ nuclear sampling method, systematic random sampling of nuclei is not only superior with respect to reproducibility of results, but also provides a better prognostic value in patients with invasive breast cancer.
References
Bonnadonna G, Rossi A, Valagussa P: Adjuvant CMF chemotherapy in operable breast cancer: ten years later. Lancet ii: 976–977, 1985
Bonnadonna G, Valagussa P, Rossi Aet al.: Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5: 95–115, 1985
Early Breast Cancer Trialists Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med 319: 1685–1692, 1988
Bon-Martens MJH, Verbeek ALM, Peeters PHM, Luning P, Werre JM: Een overzicht van de epidemiologie van borstkanker in Nederland. Ned Tijdschr Geneeskd 134: 287–291, 1990
Nemoto R, Vana J, Bedwani RH, Baker HW, McGregor FH, Murphy GP: Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45: 2917–2924, 1980
Baak JPA, van Dop H, Kurver PHJ, Hermans J: The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374–382, 1985
van der Linden JC, Lindeman J, Baak JPA, Meijer CJLM, Hermans CJ: The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 10: 56–61, 1989
Tosi P, Luzi P, Sforza V, Santopieto R, Bindi M, Tucci E, Barbini P, Baak JPA: Correlation between morphometrical parameters and disease-free survival in ductal breast cancer treated only by surgery. Appl Pathol 4: 33–42, 1986
Uyterlinde AM, Baak JPA, Schipper NW, Peterse H, Matze E, Meijer CJLM: Further evaluation of the prognostic value of morphometric and flow cytometric features in breast cancer patients with long term follow up. Int J Cancer 45: 1–7, 1990
Uyterlinde AM, Schipper NW, Baak JPA: Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer. J Clin Pathol 40: 1432–1436, 1987
Uyterlinde AM, Schipper NW, Baak JPA, Peterse H, Matze E: Limited prognostic value of cellular DNA content to classical and morphometric parameters in invasive ductal breast cancer. Am J Clin Pathol 86: 301–307, 1988
van der Linden JC, Baak JPA, Lindeman J, Hermans J, Meijer CJLM: Prospective evaluation of the prognostic value of morphometry in primary breast cancer patients. J Clin Pathol 40: 302–306, 1987
Baak JPA, Ladekarl M, Sörensen FB: Reproducibility of mean nuclear volume and correlation with mean nuclear area in breast cancer: an investigation of various sampling schemes. Hum Pathol 25: 88–85, 1994
Baak JPA, Kurver PHJ, De Snoo-Nieuwlaat AJEet al.: Prognostic indicators in breast cancer - morphometric methods. Histopathol 6: 327–339, 1982
van Bogaert LJ, van Muyler C: Nuclear diameters of breast cancer cells in tissue sections. Analyt Quant Cytol 2: 55–58, 1980
van Diest PJ, Baak JPA: The morphometric multivariate prognostic index (MPI) is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients. Hum Pathol 22: 326–330, 1991
Fossa SD, Marton PF, Knudesen OS, Kallhus O, Bormer O, Vaage S: Nuclear Feulgen DNA content and nuclear size in human breast carcinoma. Hum Pathol 13: 626–630, 1982
Zajdela A, de la Riva LS, Ghossein NA: The relation of prognosis to the nuclear diameter of breast cancer cells obtained by cytologic aspiration. Acta Cytol 23: 75–80, 1979
Fleege JC, van Diest PJ, Baak JPA: Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest 63: 270–275, 1990
Fleege JC, van Diest PJ, Baak JPA: Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections: Refinement and multi observer evaluation. Analyt Quant Cytol Histol 4: 281–289, 1993
Baak JPA, Noteboom E, Koevoets JJM: The influence of fixatives and other variations in tissue processing on nuclear morphometric features. Analyt Quant Cytol Histol 11: 219–224, 1989
Fleege JC, Baak JPA, Smeulders AWM: Analysis of measuring system parameters that influence reproducibility of morphometric assessments with a graphic tablet. Hum Pathol 19: 513–517, 1988
Baak JPA: A Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Springer, Heidelberg, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jannink, I., Bennen, J.N., Blaauw, J. et al. At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients. Breast Cancer Res Tr 36, 55–60 (1995). https://doi.org/10.1007/BF00690185
Issue Date:
DOI: https://doi.org/10.1007/BF00690185